Medical Marijuana, Inc.

MJNA

US58463A1051

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 03:48:28 2024-05-10 pm EDT			5-day change	1st Jan Change
0.0022 ^USD	-4.35%		+10.00%	-40.54%

2023	AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.	CI
2023	Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	CI

Medical Marijuana, Inc. Provides Earnings Guidance for 2013 and 2014

February 18, 2013

Medical Marijuana, Inc. provided earnings guidance for 2013 and 2014. The company forecasts revenue for 2013 to be $47,000,000 with operating cash flows of $32,000,000 and has the potential to increase revenues in 2014 to $155,000,000 with operating cash flows of approximately $95,000,000.

Latest news about Medical Marijuana, Inc.

AXIM Biotechnologies, Inc. announced that it expects to receive $0.75 million in funding from Medical Marijuana, Inc.	Dec. 25	CI
Medical Marijuana, Inc. acquired Essentially all Operating Assets of KZ1 for $5 million.	23-07-31	CI
Medical Marijuana, Inc. Announces Executive Changes	23-03-14	CI
Medical Marijuana, Inc. Appoints Dr. Timothy R. Scott as Its New Chief Executive Officer	23-03-14	CI
Medical Marijuana, Inc. Launches Pharma Subsidiary in Brazil; Expands Access to CBD Products in Pharmacies	22-05-26	CI
Medical Marijuana, Inc. Promotes Todd Morrow to President	22-02-10	CI
Jushi : Q2 Net Income Rises Year Over Year as Revenues Improve; Set to Open 21st Retail Location Nationwide	21-08-25	MT
Sector Update: Health Care Stocks Back on Positive Ground This Afternoon	21-07-27	MT
Khiron Life Sciences : Up 8.8% as Colombia Expands Medical Marijuana Program and Relaxes Export Rules	21-07-26	MT
Kanabo : UK's Kanabo to buy Canadian cannabis producer Materia	21-07-26	RE
Update: Curaleaf Loses 2% as Opens New Store in Wells, Maine	21-07-23	MT
Curaleaf : Opens New Store in Wells, Maine	21-07-23	MT
Jushi : Says Franklin Bioscience OH Begins Operations at Ohio Processing Facility	21-07-07	MT
Agrify : Secures $12 Million Contract From Nevada Medical Marijuana Dispensary	21-06-24	MT
Medical Marijuana, Inc. Announces Executive Changes	21-06-17	CI
Medical Marijuana, Inc. Announces Chief Executive Officer Changes	21-06-17	CI
A New York Prison Locked Men Up For Drugs. Now the Site Will Grow Marijuana	21-05-31	DJ
Khiron Life Sciences : First Quarter Loss Narrows on Higher Medical Sales in Colombia	21-05-27	MT
Health Care Up Amid Optimism About Insurer Growth -- Health Care Roundup	21-05-13	DJ
Cannabis Goes Corporate : Lobbyists, Unions Seek to Shape Marijuana Industry	21-05-08	DJ
Sector Update: Health Care Stocks Surge Despite Monday Weakness Among Biotech Shares	21-05-03	MT
Aurinia Pharmaceuticals : TSX rises after materials boost, positive factory data	21-05-03	RE
Jayex Healthcare : Subsidiary Receives New Zealand Medical Marijuana Cultivation License	21-04-12	MT
Curaleaf : Buying EMMAC Life Sciences for US$286 Million to Expand In Europe's Medical Marijuana Market	21-03-09	MT
Advocates Back Legislative Effort to Legalize Marijuana in New York	21-02-28	DJ

Chart Medical Marijuana, Inc.

Duration

Period

More charts

Company Profile

Medical Marijuana, Inc. manufactures and distributes natural health, beauty and hemp-derived cannabidiol (CBD) products through e-commerce, direct sales, retail and wholesale distribution channels. It operates in three divisions. Medical Marijuana, Inc. division operates its Website to maintain an online presence, provide corporate, investor relations and educational information and news relating to it and the cannabis industry. HempMeds division distributes products directly in the United States and through its subsidiaries internationally primarily in Mexico and Brazil. The division's product is Real Scientific Hemp Oil (RSHO). RSHO is a full spectrum, complete CBD hemp oil, which contains the natural hemp oil in the industry. RSHO is offered in three varieties: Green, Blue and Gold. Kannaway is its direct selling division, which sells its CBD products in United States, Europe and Asia. Its product also includes Focus, which contains Nootropics that helps support cognitive function.

Sector

Pharmaceuticals

Calendar

2024-05-21 - Q1 2024 Earnings Release (Projected)

More about the company